JHL Biotech raises $35M in series B

JHL Biotech Inc. (Zhubei, Taiwan) raised $35 million in a series B round led by new investor Milestone Capital. Other new investors in the round were President International Development Corp.; Fubon Financial Holdings; Taishin Financial Holdings; TaiAn Technologies; Hotung Group; and Allen Chao, founder and former chairman and CEO of Watson Pharmaceuticals, which became Actavis plc (NYSE:ACT) last year. Existing investors China Development Investment Bank; Biomark Capital; and Kleiner Perkins Caufield & Byers also participated in the round. ...